KoBioLabs, Inc (KOSDAQ:348150)
3,780.00
+170.00 (4.71%)
At close: Jun 5, 2026
KoBioLabs Revenue
KoBioLabs had revenue of 19.22B KRW in the quarter ending March 31, 2026, with 11.10% growth. This brings the company's revenue in the last twelve months to 71.21B, up 0.61% year-over-year. In the year 2025, KoBioLabs had annual revenue of 69.29B with 1.36% growth.
Revenue (ttm)
71.21B
Revenue Growth
+0.61%
P/S Ratio
1.03
Revenue / Employee
n/a
Employees
n/a
Market Cap
73.40B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 69.29B | 932.96M | 1.36% |
| Dec 31, 2024 | 68.36B | 35.22B | 106.28% |
| Dec 31, 2023 | 33.14B | 21.53B | 185.54% |
| Dec 31, 2022 | 11.61B | 8.71B | 301.12% |
| Dec 31, 2021 | 2.89B | -1.70B | -36.98% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CTCBIO | 128.76B |
| Naturalendo Tech | 21.69B |
| BIO-FD&C | 18.85B |
| Ark Solutions | 17.95B |
| PanGen Biotech | 13.71B |
| TegoScience | 5.83B |
| EyeGene | 4.02B |
| SunBio,Inc. | 2.17B |